APITOPE
Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, Factor VIII intolerance and uveitis. The company, whose first product candidate is licensed to Merck Serono, will now progress its remaining portfolio of product candidates developed with its proprietary platform technology.
APITOPE
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2002-01-01
Address:
Bristol, Bristol, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.apitope.com
Total Employee:
11+
Status:
Active
Total Funding:
22 M EUR
Technology used in webpage:
Person Schema Gravatar Profiles Gravity Forms British Server Location
Similar Organizations
Aerogen
Aerogen is a medical device and drug delivery company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
SA Biotech
SA Biotech is a Healthcare company.
Current Employees Featured
Founder
Investors List
Limburgse Reconversie Maatschappij
Limburgse Reconversie Maatschappij investment in Series B - Apitope
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series B - Apitope
PMV Pharmaceuticals
PMV Pharmaceuticals investment in Series B - Apitope
Wyvern Seed Fund
Wyvern Seed Fund investment in Series B - Apitope
Arthurian Life Sciences
Arthurian Life Sciences investment in Series B - Apitope
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series A - Apitope
Vinnof
Vinnof investment in Series A - Apitope
Official Site Inspections
http://www.apitope.com
- Host name: 176.58.126.104
- IP address: 176.58.126.104
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V
More informations about "Apitope"
Apitope - Crunchbase Company Profile & Funding
Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including …See details»
Apitope 2025 Company Profile: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Apitope. Use the PitchBook Platform to explore the full profile.See details»
Apitope - Products, Competitors, Financials, Employees, …
Apitope is a European biotech company focused on the discovery and development of revolutionary disease modifying therapies for autoimmune and allergic diseases, including …See details»
Apitope - VentureRadar
"Apitope International NV is a biopharmaceutical company with its head office in Diepenbeek, Belgium, and a subsidiary in Bristol, United Kingdom. The company develops trail-blazing …See details»
Apitope Company Profile - Office Locations, Competitors ... - Craft
Apitope has 5 employees across 2 locations and $26.22 m in total funding,. See insights on Apitope including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Apitope - Funding, Financials, Valuation & Investors - Crunchbase
In funding over 3 rounds. Their latest funding was raised on Sep 29, 2015 from a Series B round. Apitope is funded by 6 investors. Limburgse Reconversie Maatschappij and Vesalius …See details»
Apitope - LinkedIn
Apitope | 1,521 followers on LinkedIn. Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis of ...See details»
Apitope - Company Profile - Tracxn
Feb 25, 2025 Apitope - Developer of therapeutic peptides for the treatment of autoimmune and allergic diseases. Raised a total funding of $26.6M over 2 rounds from 9 investors. Founded …See details»
Apitope International N.V. - Life-Sciences-Europe.com
Jan 13, 2009 Apitope is a clinical stage biotech company that develops potential first-in-class antigen-specific immunotherapies targeting autoimmune diseases. Apitope uses its novel, …See details»
Apitope – World-leading clinical-stage biotech firm, …
October Edition 2020 Apitope – World-leading clinical-stage biotech firm, developing antigen-specific immunotherapeutics for autoimmune diseasesSee details»
Home - Epitopea
Feb 19, 2025 Epitopea is a transatlantic cancer immunotherapeutics company based in Montreal, Canada and Cambridge, UK. Our proprietary CryptoMap TM platform, created and optimized by Drs. Claude Perreault and Pierre Thibault …See details»
Apitope International NV - Diepenbeek, Belgium - bionity.com
Jun 11, 2015 Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis of autoimmune …See details»
Apitope CEO and Key Executive Team - Craft.co
Apitope's Chief Executive Officer is Hayley French. Other executives include Stéphane Verdood, Non-Executive Director; Chairman of the Board; Liselotte Jansson, Chief Research Officer and …See details»
Apitope’s Competitors, Revenue, Number of Employees, Funding …
Apitope’s Profile, Revenue and Employees. Apitope develops antigen-specific immunotherapies for the treatment of autoimmune diseases. Apitope’s primary competitors include Kineta, …See details»
Apitope International Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Apitope International of Diepenbeek, Limburg. Get the latest business insights from Dun & Bradstreet.See details»
Interview with Keith Martin, CEO, Apitope
Mar 13, 2012 Apitope’s research and success is based on its High Speed Technology Platform that uses soluble…See details»
Apitope Treatment Approach Published in Nature Communications
Sep 4, 2014 Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today …See details»
Apitope | VentureRadar
Apitope International NV is a biopharmaceutical company with its head office in Diepenbeek, Belgium, and a subsidiary in Bristol, United Kingdom. The company develops trail-blazing …See details»
Rope Access Services Melbourne | API Rope Access
Book the best Rope Access Services Melbourne has to offer. Elevate your project with API Rope Access now and get high quality services. Get a free quote today!See details»
Apitope - LinkedIn
Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis of autoimmune diseases. We use our …See details»